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Abstract
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a genetic
paradigm of small vessel disease (SVD) caused by NOTCH3 mutations that stereotypically lead to the vascular
accumulation of NOTCH3 around smooth muscle cells and pericytes. White matter (WM) lesions (WMLs) are the
earliest and most frequent abnormalities, and can be associated with lacunar infarcts and enlarged perivascular
spaces (ePVS). The prevailing view is that blood brain barrier (BBB) leakage, possibly mediated by pericyte
deficiency, plays a pivotal role in the formation of WMLs. Herein, we investigated the involvement of BBB leakage
and pericyte loss in CADASIL WMLs. Using post-mortem brain tissue from 12 CADASIL patients and 10 age-
matched controls, we found that WMLs are heterogeneous, and that BBB leakage reflects the heterogeneity.
Specifically, while fibrinogen extravasation was significantly increased in WMLs surrounding ePVS and lacunes, levels
of fibrinogen leakage were comparable in WMLs without other pathology (“pure” WMLs) to those seen in the
normal appearing WM of patients and controls. In a mouse model of CADASIL, which develops WMLs but no
lacunes or ePVS, we detected no extravasation of endogenous fibrinogen, nor of injected small or large tracers in
WMLs. Moreover, there was no evidence of pericyte coverage modification in any type of WML in either CADASIL
patients or mice. These data together indicate that WMLs in CADASIL encompass distinct classes of WM changes
and argue against the prevailing hypothesis that pericyte coverage loss and BBB leakage are the primary drivers of
WMLs. Our results also have important implications for the interpretation of studies on the BBB in living patients,
which may misinterpret evidence of BBB leakage within WM hyperintensities as suggesting a BBB related
mechanism for all WMLs, when in fact this may only apply to a subset of these lesions.
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Introduction
Cerebral small vessel disease (SVD) is the leading cause of
vascular dementia and a major contributor to stroke and
disability [37]. Cerebral autosomal dominant arteriopathy
with subcortical infarcts and leukoencephalopathy
(CADASIL) is the most common monogenic form of
SVD, affecting 2–5 in 100,000 people [43]. It is caused by
mutations in the NOTCH3 gene which lead to the charac-
teristic and early accumulation of the NOTCH3 extracel-
lular domain (Notch3ECD) around smooth muscle cells
and pericytes in patients and mice with CADASIL [8, 25–
27, 31, 45, 50].
CADASIL is a genetic paradigm of SVD which presents
with all clinical and neuroimaging features of sporadic
SVD [6]. CADASIL resembles sporadic SVD to such an
extent that it has been used as a model in trials of drugs
to treat vascular dementia [16]. One of the hallmarks of
SVD is the presence of white matter hyperintensities
(WMH) on magnetic resonance imaging (MRI) of the
brain. WMH are the earliest and most frequent MRI ab-
normalities in CADASIL patients, appearing as puncti-
form lesions from around 30 years of age and becoming
more diffuse and symmetrical with age. While predomin-
ating in the periventricular areas and the centrum
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semiovale, WMH occur at three locations which are
highly suggestive of CADASIL: the anterior part of the
temporal lobes, the external capsules, and the superior
frontal gyri [6]. WMH on MRI are associated with cogni-
tive decline in both the general population and high risk
groups, though brain atrophy is a stronger determinant of
clinical impairment in CADASIL patients [14, 47].
Another defining pathology of SVD is the presence of
lacunes, fluid-filled cavities presumed to be the healed
stages of deep brain infarcts [48]. These can be found
throughout the white matter (WM) and the deep grey
matter (GM) in the brain. In CADASIL, lacunes essen-
tially occur within the same area as WM lesions, but at a
later age than WM lesions [6]. Enlarged perivascular
spaces (ePVS) have recently been recognised as another
key feature of SVD on MRI and are thought to correspond
to enlarged spaces around arteries and arterioles allowing
freer movement of water [48]. The resolution limits of
conventional MRI sequences mean that it is predomin-
antly larger ePVS (> 1mm diameter) around penetrating
arteries which are easily visible, and the profile of follow-
ing a vessel is key to distinguishing these from smaller
lacunes [48]. A high density of ePVS is also seen in the
basal ganglia, in a state termed “état criblé”. CADASIL pa-
tients show ePVS with a similar distribution, as well as a
high density of ePVS in the temporal lobe [11].
The mechanisms by which white matter lesions
(WMLs) form in SVD, and CADASIL in particular, re-
main elusive, however it has been suggested that a loss
of integrity of the blood brain barrier (BBB) is pivotal in
their pathophysiology [24, 38]. The BBB is the structure
which prevents substances from the blood entering the
brain parenchyma [1]. It is formed by tight junctions
(TJs) between brain endothelial cells, and its function is
supported by pericytes, the mural cells around capillar-
ies. Notably, a loss of pericytes in the mouse increases
the permeability of the BBB to water and a range of low
and high molecular weight molecules [2, 12]. Investiga-
tions into the integrity of the BBB in sporadic SVD have
shown mixed results, with some MRI and biochemical
studies suggesting an increase in BBB permeability [18],
while other histopathological studies have suggested that
this is not the case [4]. This discrepancy may reflect dif-
ferences in sensitivity or reliability of the different tech-
niques used. The possibility that WMLs in SVD might
be caused by an increase in BBB permeability has been
bolstered by recent work in pericyte deficient mice sug-
gesting a pathological link between BBB breakdown and
WM pathology; it has been suggested that in this model
fibrinogen toxicity can cause oligodendrocyte death and
WM damage [32]. However, the integrity of the BBB has
not been studied in the WM in CADASIL.
Here, we tested the hypothesis that pericyte loss and
subsequent BBB breakdown may cause WMLs in
CADASIL. To achieve this, we studied post-mortem
brains from CADASIL patients that represent the whole
spectrum of the disease. We also used a well-established
mouse model of CADASIL, allowing us to perform
in vivo studies and study an early stage of the disease
process.
Methods
Human brain tissue
Ethical approval for the use of human tissue was pro-
vided by the INSERM Institutional Review Board
(IRB00003888) to AJ. Tissue was collected in line with
local guidelines. Post-mortem human brain tissue from
the frontal lobe (with two exceptions, see Additional
file 1: Tables S1-S2) was analysed in two cohorts. The
first cohort included eight CADASIL patients and six
controls with no neurological disease, with samples from
Paris (INSERM and GIE-NeuroCeb brain bank), Turku
University and the University of Edinburgh. These sam-
ples were provided as paraffin embedded blocks, and
sectioned at 5 μm onto standard microscope slides (25
mm × 75mm). The controls and patients in this cohort
were 50 and 50% male respectively; 60.8 ± 14.7 (mean ±
standard deviation) and 62.9 ± 9.2 years old respectively;
and had a post-mortem delay of 18.6 ± 9.4 and 16.9 ±
8.9 h respectively. The second cohort included four
CADASIL patients and four controls with samples pro-
vided by Newcastle University as 10 μm thick paraffin
sections on large microscope slides (50 mm × 75mm).
The controls and patients in this cohort were 25 and
50% male respectively; 62.5 ± 10.5 and 60.8 ± 8.5 years
old respectively; and had a post-mortem delay of 39.5 ±
11.8 and 21.3 ± 6.2 h respectively. Full details of the hu-
man controls and patients can be found in Add-
itional file 1: Tables S1-S2.
Animals
Animal experiments were conducted in full accordance
with the guidelines of our local institutional Animal
Care and Use Committee (Lariboisière-Villemin, CEA9).
TgNotch3WT mice and TgNotch3R169C mice were main-
tained on an FVB/N background and overexpress the rat
Notch3 gene, either in the wild type form or containing
the mutation R169C found in CADASIL patients re-
spectively [27]. These mice were used at ages between
14 and 16months. Col4a1+/G498V mice were maintained
on a C57BL/6 background and bear a mutation in the
Col4a1 gene which is found in HANAC syndrome pa-
tients [7]. HANAC syndrome is another genetic form of
SVD, which is part of Collagen type IV related SVD, and
mice bearing this mutation have previously been shown
to display a transient defect of the BBB at 1 month of
age which disappears with age [42]. These mice were
used at 1 month of age.
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Injection of tracers
Mice were injected by tail vein injection with either 100 μl
of cadaverine-AF555 (0.5mg/ml; ThermoFisher; A30677)
or 200 μl of a combination of a 70 kDa biotinylated dex-
tran (12.5mg/ml; ThermoFisher; D1857) and albumin-
AF488 (5mg/ml; ThermoFisher; A34781). Col4a1+/G498V
mice (cadaverine) or drill injury mice (dextran and albu-
min) served as positive controls. Cadaverine was used as
its small molecular weight (950Da) is close to the size
limit for passive paracellular transport across endothelial
TJs [35]. Thus, it is sensitive to even a minor disruption to
TJs [2]. The tracers were allowed to circulate for 2 h (ca-
daverine) or 24 h (dextran and albumin) before the animal
was terminated by intracardiac perfusion of heparinised
phosphate buffered saline (PBS) followed by 4% PFA.
Brains were extracted and split into hemispheres which
were post-fixed in 4% PFA at 4 °C for either 1 h (for peri-
cyte assessment) or overnight (to assess BBB leakage).
Drill injury
Buprenorphine (0.1mg/kg) was administered to the mice.
After 30min, ketamine-xylazine (75mg/kg-5mg/kg) was
administered. Once the animal was sleeping, the head was
raised and disinfected in Betadine, and affixed to a stereo-
tactic frame. An incision was made in the scalp, and a 1
mm diameter hole drilled in the skull, before the skin was
sutured with Dafilon 5.0 sutures. The mice were moni-
tored until waking, with extra doses of buprenorphine
injected 6 h after the surgery, and the following morning.
Immunostaining of mouse tissue
Brains were sectioned sagittally using a vibratome at ei-
ther 50 μm (one-hour post-fixed tissue) or 30 μm (tissue
post-fixed overnight). At least three non-adjacent sec-
tions (> 100 μm apart) were analysed per animal per
condition. Sections were processed as floating sections.
Sections which had been post-fixed overnight underwent
antigen retrieval (incubated in 0.25% trypsin for 5 min at
37 °C, followed by 3 × 5min washes in PBS). Sections
were blocked for 2 h at room temperature on an orbital
shaker in blocking solution (5% donkey serum, 0.1% tri-
ton in PBS). Sections were incubated with primary anti-
bodies [Fibrinogen (1:5000; Dako; A0080), Glut-1 (1:500;
ThermoFisher; MA5–11315), Glut-1 (1:10,000; Milli-
pore; 07–1401), PDGFR-β (1:500; eBioscience; 14–1402-
82), Aminopeptidase-N/CD13 (1:250; R&D Systems;
AF2335)] in blocking solution overnight at 4 °C on a
shaker. Sections were then washed in PBS (3 × 5min)
before being incubated with Alexa Fluor secondary anti-
bodies for 4 h at room temperature on a shaker. Sections
were washed in PBS (3 × 5min), incubated with DAPI
(1 min at room temperature), further washed in PBS
(3 × 5min), then mounted on slides with Dako Mount-
ing Medium.
Immunostaining of human tissue
Sections from paraffin blocks were cut at either 5 μm (co-
hort 1) or 10 μm (cohort 2) using a microtome. All sam-
ples from a cohort were processed and analysed in a
single batch to minimise technical variability. Sections
were deparaffinised by immersion in Toluene (2 × 2min)
and rehydrated by immersion in descending concentra-
tions of ethanol (100, 100, 70, 50, 30%; 10 s each) before
being immersed in tap water (5min). Sections were incu-
bated in 3% hydrogen peroxide (20min at room
temperature), followed by washing in PBS (2 × 2min) be-
fore antigen retrieval was carried out (boiling for 10min
in citrate buffer (Vector) in a microwave). Sections were
then cooled for 10min in running tap water. Sections
were blocked for 2 h at room temperature in blocking so-
lution (for Fibrinogen: 10% goat serum, 0.1% triton in
PBS; for PDGFR-β and Glut-1: 10% foetal calf serum, 0.3%
triton in PBS). Sections were washed in PBS then incu-
bated with primary antibodies [Fibrinogen (1:2500; Dako;
A0080), PDGFR-β (1:50; R&D Systems; AF385), Glut-1 (1:
500; Millipore; 07–1401)], Glial fibrillary acidic protein
(GFAP) (1:500; Sigma-Aldrich; G-9269) in blocking solu-
tion overnight at either 4 °C (Fibrinogen) or room
temperature (PDGFR-β and Glut-1). Sections were
washed in PBS (3 × 5min) then incubated with biotinyl-
ated secondary antibodies for 1 h (Fibrinogen) or 2 h
(PDGFR-β and Glut-1) at room temperature. Sections
were washed in PBS (3 × 2min) then incubated with VEC-
TASTAIN ABC reagent (Vector) for 30min at room
temperature. Sections were washed in PBS (3 × 2min)
then incubated with 3,3′-diaminobenzidine (DAB; Ther-
moFisher) for 5min (Fibrinogen, Glut-1) or 30min
(PDGFR-β). Sections were washed twice in distilled water,
followed by tap water (1min), then dehydrated (10 s each
in 30, 50, 70, 100, 100% ethanol; followed by 2 × 2min in
Toluene for mounting) and mounted using Eukit.
Histological stains
Luxol fast blue staining
Sections were deparaffinised by immersion in toluene (2 × 2
min) and partially rehydrated in ethanol (100, 95, 95, 95%;
30 s each). Sections were incubated in Luxol Fast Blue (LFB)
overnight at 37 °C. Sections were then rinsed in 3 baths of
MilliQ water, then differentiated in 0.025% lithium carbonate
solution (30 s) followed by 70% ethanol (20 s), then rinsed in
3 baths of distilled water. Sections were then incubated with
0.1% cresyl fast violet for 10min at room temperature and
washed in 3 baths of MilliQ water. Sections were then deco-
loured in 95% ethanol (3 s), dehydrated in 100% ethanol (5 s),
immersed in toluene (2 × 2min) and mounted in Eukit.
Haematoxylin and eosin staining
Sections were deparaffinised and rehydrated as for im-
munostaining. Sections were immersed in a bath of
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Harris haematoxylin for 30 s, then rinsed briefly in 2
baths of tap water followed by differentiation in tap
water (1 min). Sections were then immersed in a bath of
1% eosin for 30 s followed by brief rinsing in 2 baths of
tap water, before being dehydrated and mounted as for
immunostaining.
Imaging and analysis
Mouse tissue
Fluorescent images were acquired using a Leica SP8 con-
focal microscope, capturing a 25 μm thick stack with op-
tical sections taken at 2 μm intervals. At least 2 fields of
view were captured systematically from the most anterior
and most posterior regions of the corpus callosum per
section, and at least 3 sections were analysed per animal.
Human tissue
Bright-field images were acquired using either a Hamama-
tsu Nanozoomer (cohort 1) or Zeiss AxioScan (cohort 2)
slide scanner, allowing us to analyse entire sections instead
of a random selection of fields. Classification of WMLs
was carried out by selecting regions of myelin pallor on an
overview of the LFB stained section, and then examining
enlargements of these regions on LFB and H&E side-by-
side. WMLs around lacunes were defined as the entire
area of myelin pallor on LFB around a lacune – this ex-
tended 150-600 μm from the edge of the lacune. ePVS
WMLs were defined as regions of myelin pallor on LFB
enriched in ePVS, which were often clustered. Where pos-
sible, fibrinogen extravasation was analysed on the entire
lesion area using slide scanned images – between 1 and
20mm2 of tissue was analysed from each region per case.
BBB leakage was quantified using the Fiji distribution
of ImageJ (open source), by automated measuring of the
integrated density (encompassing both area and intensity
of staining) after applying a size cut-off (mouse: > 5 μm
diameter) and intensity thresholds (human: > 50, mouse:
based on local mean intensity) to remove the back-
ground. Pericyte coverage in human tissue was assessed
by staining for pericytes and vessels on adjacent sections,
and quantified in ImageJ using a semi-automated
method to calculate stained area, after manually exclud-
ing large vessels (> 10 μm) to assess only capillaries. Peri-
cyte coverage in mouse was assessed automatically by
creating a mask of the vascular area, and calculating
pericyte stained area within this mask. Pericyte number
in mouse tissue was quantified manually. The experi-
menter was blinded to the genotype throughout quanti-
fications which were carried out manually.
Statistics
Graphs were created and statistics calculated using Graph-
Pad Prism. All data are shown as mean ± standard error of
the mean (SEM). The number of biological replicates used
in each experiment is indicated in the figure or figure le-
gend. Significance was calculated using either a one-way
or two-way ANOVA with Tukey’s post-hoc tests.
Results
WMLs in CADASIL patients encompass at least three
categories of damage
MRI studies in CADASIL patients have shown that
lacunes and ePVS can occur in the same areas as WMH
[6]. Therefore, before examining the BBB and pericyte
integrity in post-mortem brains from patients, we first
characterised the nature of WM damage. We studied 12
CADASIL patients from two separate cohorts and fo-
cused mostly on the frontal WM, as we have shown pre-
viously that the frontal lobe including WM bears the
brunt of vascular pathology in CADASIL patients [8–10,
22]. We used Luxol Fast Blue (LFB) staining for myelin
and Haematoxylin & Eosin (H&E) staining for general
tissue structure on serial sections from paraffin embed-
ded brains (Fig. 1). To facilitate distinction of different
regions, we used a slide scanner to provide a high reso-
lution overview of the entire section. We found that
WM in CADASIL patients is more heterogeneous than
is usually given consideration [20, 52]. As has been pre-
viously reported [29, 36], the myelinated U-fibres were
spared and all the patients in our cohorts had some nor-
mal appearing WM (NAWM; Fig. 1a-c) as well as le-
sioned WM. These areas of WML were separated into
three categories based on other pathological findings.
Lacunes on MRI are usually defined as being larger than
3mm in diameter [48]. On histopathological sections, we
detected smaller lacunes in the WM (Additional file 1:
Figure S1) – as small as 300 μm in diameter (Fig. 2m), i.e.
much smaller than the detection threshold of conven-
tional 3 T MRI. Where tissue was available, reactive astro-
cytosis was assessed using GFAP staining and was
observed around some but not all lacunes (Additional
file 1: Figure S2), as expected from our previous data
showing varied astrocytic responses in more recent in-
farcts [22]. We found that irrespective of the size of the
lacune, myelin pallor was found around the border of
WM lacunes, extending 150-600 μm from the edge of the
lacune, that we define here as the first category of WML
(Fig. 1h-i). Myelin pallor has previously been described
around lacunes in ageing [29], but these are not usually
analysed as a separate category of WML.
We next assessed the distribution of ePVS in the
WM, and found these predominantly close to the
boundary between GM and WM, at the cortico-
subcortical junction (Fig. 1a). Surrounding these
ePVS, we found regions of myelin pallor as the sec-
ond category of WML (Fig. 1d-e). Few studies have
characterised ePVS histopathologically, however an as-
sociation between ePVS and WM damage has
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Fig. 1 (See legend on next page.)
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previously been shown in CADASIL [13, 51]. The
patches of WM damage that we observed here around
ePVS bear some similarity to lesions which have pre-
viously been described as microinfarcts, with non-
uniform disorganisation of tissue structure on H&E
stained sections and sizes less than 500 μm in diam-
eter [28, 46]. This distinct patterning on H&E
strongly suggests that these are a distinct type of le-
sion from “pure” WMLs to be described below. We
have, for the present purposes, chosen not to use the
terminology of microinfarcts, as this term is not well
defined and implies a known pathogenic mechanism.
However, in common with microinfarcts, the small
size of areas of WM damage around ePVS (ePVS
WMLs) precludes reliable detection on conventional
MRI sequences.
The third category of WML, which we term “pure”
WMLs, exhibits myelin pallor on LFB, with a
homogenous structure on H&E, and does not contain
any other overt pathology (Fig. 1f-g). These lesions were
found exclusively in areas of deep, non-periventricular
white matter (> 10 mm from the surface of the brain).
(See figure on previous page.)
Fig. 1 White matter lesions (WMLs) are heterogeneous in CADASIL patients. a Luxol Fast Blue (LFB) stained tissue section from the frontal lobe of
a CADASIL patient, with different categories of white matter (WM) indicated. b-i LFB (b, d, f, h) and Haematoxylin & Eosin (c, e, g, i) stained
images showing the regions highlighted in (a) in greater detail: 1. Normal appearing WM (b-c); 2. Lacune (h-i); 3. Enlarged perivascular space
(ePVS) WML (d-e); 4. “Pure” WML (f-g). Scale bar: (a) 1 mm; (b-i) 50 μm
Fig. 2 Regional heterogeneity of fibrinogen extravasation based on the category of white matter (WM) lesion (WML) in CADASIL patients. Luxol
fast blue stained (a, d, g, j, m), Haematoxylin & Eosin (H&E) stained (b, e, h, k, n) and Fibrinogen immunostained (c, f, i, l, o) serial sections from
a control brain (a-c), and from normal appearing WM (NAWM) (d-f), “pure” WML (g-i), enlarged perivascular space (ePVS) WML (j-l) and damaged
WM around a lacune (m-o) in the brain of a CADASIL patient. Graphs show quantification of fibrinogen staining in the first (p) and second (q)
cohorts of CADASIL patients. Mean ± SEM; *: p < 0.05, **: p < 0.01; one-way ANOVA with Tukey’s post-hoc tests; cohort 1: n = 6 (controls), 8 (patients);
cohort 2: n = 4 (controls), 4 (patients). Scale bar: 50 μm
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Regional heterogeneity of white matter fibrinogen
extravasation in CADASIL patients
We next evaluated the integrity of the BBB in human
post-mortem tissue sections with respect to these differ-
ent categories of WML. We performed DAB immuno-
staining for fibrinogen and quantified the integrated
density of staining in different regions, incorporating
both diffuse parenchymal staining and cellular uptake.
We chose fibrinogen as a marker of BBB leakage due to
its relevance to WMLs – in a mouse model of pericyte
loss and BBB leakage, fibrinogen was suggested to be re-
sponsible for WM loss through its toxicity to oligoden-
drocytes [32]. We also used tissue from an acute stroke
patient as a positive control to validate our immuno-
staining (Additional file 1: Figure S3). In the brains of
our first cohort of CADASIL patients, we found strong
fibrinogen staining, including cellular uptake, around the
edges of lacunes (Fig. 2m-o, p) and in regions of ePVS
WMLs (Fig. 2j-l, p). Morphological examination on
higher magnification images suggests that both astro-
cytes and oligodendrocytes take up fibrinogen (Add-
itional file 1: Figure S4). However, in regions of the
brain with “pure” WMLs (Fig. 2g-i, p), without other
pathology, levels of fibrinogen leakage were comparable
to those seen in the normal appearing white matter
(NAWM) of CADASIL patients (Fig. 2d-f, p) and age-
matched controls (Fig. 2a-c, p).
To confirm this finding, we examined brains from four
patients and four controls from a second cohort where
we had much larger and thicker tissue sections, allowing
us to better examine deep WM. In this cohort, we simi-
larly found BBB leakage around WM lacunes and ePVS
WMLs at the grey/white matter boundary, but no leak-
age in deeper “pure” WMLs or NAWM (Fig. 2q).
These data show that while there was evidence of BBB
leakage in damaged WM in CADASIL patients, this is
regionally heterogeneous. BBB leakage was present
where there are ePVS or lacunes, but was not a consist-
ent feature of WMLs in CADASIL.
No appreciable loss of pericytes in the WM of CADASIL
patients
We then assessed pericyte integrity in WM capillaries
with respect to the different categories of WML. A pre-
vious study examining the frontal WM of CADASIL pa-
tients found a small increase in the PDGFR-β stained
area compared to controls, but this did not distinguish
between different WM areas or fully account for possible
changes in capillary density [8]. We stained serial sec-
tions of tissue from CADASIL patients with Glut-1, an
endothelial marker, and PDGFR-β, a marker of pericytes.
We manually excluded large vessels (> 10 μm) to assess
only capillaries. We found that there was a reduced ca-
pillary density in CADASIL patients compared to
controls, which was significant in “pure” WMLs and
around lacunes, but not in NAWM or ePVS WML
(Fig. 3a-b, e). However, there was no difference in the
absolute area of pericyte staining independent of capil-
lary area (Fig. 3c-d, f), nor was there a difference in the
ratio of pericyte to capillary staining (Fig. 3g).
No BBB leakage and no pericyte loss in CADASIL mice
with “pure” WML
Our findings in post-mortem tissue from human CADA-
SIL patients show that there are different types of WML,
with different BBB pathologies, although with no appre-
ciable pericyte coverage loss. However, post-mortem tis-
sue from aged patients represents a late stage of the
disease, and thus the order of pathological changes can-
not be determined. The definition of “pure” WMLs as
lacking other pathology also raises the possibility of mis-
categorisation due to missed pathology on adjacent sec-
tions. To overcome both of these obstacles, we used a
mouse model which recapitulates only the early stage of
the disease.
The TgNotch3R169C mouse is a well characterised
mouse model of CADASIL. This model overexpresses a
form of the Notch3 gene with the same mutation
(R169C) which is commonly found in patients. As a con-
trol strain, we used the TgNotch3WT mouse, which over-
expresses, through the same promoter, the wild-type
form of the Notch3 gene. This mouse model has been
previously well characterised as replicating many aspects
of CADASIL. Specifically, mutant mice exhibit Notch3-
ECD accumulation around brain smooth muscle cells and
pericytes as early as at 2 months of age, and develop
WMLs from 6 months of age which become progres-
sively more severe [5, 27]. Importantly however, these
mice do not develop lacunes, nor do they show any signs
of ePVS [27]. This allows us to study “pure” WMLs in
isolation.
While previous studies have shown WMLs in the cor-
pus callosum (CC) as a whole, we found that there is in
fact a difference in the severity of WMLs across the CC.
WMLs in the CC of CADASIL mice show an anterior-
posterior gradient, with the WM damage much more se-
vere in the anterior CC than the posterior CC (Add-
itional file 1: Figure S5). Therefore, in addition to
TgNotch3WT control animals, we were able to use the
posterior CC of TgNotch3R169C mice as an internal con-
trol, as a region with similar vascular and axonal archi-
tecture to the anterior CC but relatively normal WM.
We first assessed BBB integrity in the CADASIL
mouse by assessing parenchymal staining of endogenous
fibrinogen. As a positive control for BBB leakage to val-
idate our techniques, we used 1 month old
Col4a1+/G498V mice, which have a mild, transient BBB
leakage [42]. We found that there was no evidence of
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increased fibrinogen extravasation in CADASIL mice in
either the anterior or posterior CC (Fig. 4a-d).
We next intravenously injected tracers of different
sizes into the mice and allowed these to circulate before
assessing if they had entered the brain. As the tracers
used are much smaller than endogenous fibrinogen, they
allow the detection of a subtler BBB defect. We first
used a fluorescently conjugated cadaverine, which at
950 Da is close to the size limit of the BBB, and allowed
it to circulate for 2 h. We found no evidence of cadaver-
ine extravasation in either the anterior or posterior cor-
pus callosum of CADASIL mice, despite clear
extravasation in our Col4a1+/G498V positive control mice
(Fig. 4e-h).
While this technique allows detection of a subtle,
acute BBB leakage, it may miss a slower, chronic leakage.
We therefore injected a combination tracer of a labelled
70 kDa dextran and a labelled exogenous albumin (~ 70
kDa) and allowed these to circulate for 24 h. For these
experiments, we used wild-type mice having undergone
drill injury, which produces severe BBB leakage, as a
positive control. With these tracers, we similarly found
no leakage (Additional file 1: Figure S6).
We also examined pericytes in the WM of CADASIL
mice, where fluorescent co-staining techniques allow us
to more accurately assess the pericyte coverage of capil-
laries. We used two different markers of pericytes,
PDGFR-β and aminopeptidase-N (also referred to as
CD13), to ensure reliable quantification. We found no
difference in the capillary coverage of pericytes (Fig. 5a-
d, e, g), or in the number of pericyte cell bodies in either
the anterior or posterior CC (Fig. 5f, h).
These data together show that there is no evidence of
BBB leakiness and pericyte loss in the “pure” WMLs of
CADASIL mice, supporting our findings in the WM
from CADASIL patients.
Discussion
Here, we have shown that in CADASIL, a genetic para-
digm of SVD: 1) WMLs are heterogeneous; 2) while
there is BBB leakage in ePVS WMLs and WMLs around
lacunes, the BBB is preserved in “pure” WMLs in both
CADASIL patients and CADASIL mice; 3) there is no
loss of pericytes in any type of WML in CADASIL pa-
tients, nor in CADASIL mice. These data together indi-
cate that WMLs in CADASIL encompass distinct classes
of WM changes and argue against the prevailing hypoth-
esis that pericyte loss, mediated by BBB leakage, is the
primary driver of all WMLs. Our results also have
important implications for the biological interpret-
ation of BBB leakage in CADASIL WM assessed with
conventional 3 T MRI, since the large voxel size (~ 1
mm3) precludes reliable separation of these distinct
categories of WMLs.
Given our experimental observations presented above,
we propose a new classification of different types of
WMLs. This is especially important when considering
comparisons to MRI studies that usually define different
types of WMH based on localisation in different brain
regions or different depths within the brain, but not
based on the presence of other pathological features
within WMLs [44]. Our findings that “pure” WMLs are
exclusively located in deep WM, while ePVS WMLs
tend to be distributed in subcortical WM at the GM/
WM boundary suggests that classification of WMLs
based on depth could provide some overlap with the cat-
egories we have defined. However, the definitions of dif-
ferent regions of depth within the brain differ in MRI
studies, and the deep and subcortical WM are often
combined into a single category to be compared against
periventricular WM [44], which we unfortunately did
not have access to for this study. Moreover, the small
size of many ePVS, and even some lacunes, can make
them invisible on conventional 3 T MRI sequences,
which often cannot detect pathology smaller than 1 mm
in diameter. Thus, it is possible that WMLs associated
with these small ePVS or lacunes show up as WMHs, in-
distinguishable from “pure” WMLs. Studies on the BBB
in living patients may therefore misinterpret evidence of
BBB leakage within WMHs as suggesting a BBB related
mechanism for all WMLs, when in fact this may only
apply to a subset of these lesions. More advanced quan-
titative MRI techniques that provide biophysical para-
metric measurements, sometimes called “in vivo
histology”, may enable discrimination of these based on
different water and lipid content [13, 19], however these
methods are not in common usage.
Despite these limitations of conventional MRI se-
quences, the possibility that WM in CADASIL en-
compasses distinct classes of lesions has been
suggested by recent MRI studies [13, 17]. Lesions in
the WM of anterior temporal poles and superior
frontal gyri, which are locations highly suggestive of
CADASIL, have higher T1 and T2* relaxation times
and are associated with better cognitive and clinical
outcomes [13, 17]. Importantly, high resolution 7 T
(See figure on previous page.)
Fig. 3 No change in pericyte coverage in CADASIL patients. Immunostaining for capillary endothelium (glut-1; a-b) and for pericytes (PDGFR-β;
c-d) on serial sections from normal appearing white matter (NAWM) in a control brain (a, c) and a “pure” white matter lesion (WML) in a CADASIL
patient brain (b, d). Capillary area is quantified in (e), pericyte area is quantified in (f), and the ratio of pericyte stained area to capillary stained
area is quantified in (g). Mean ± SEM; **: p < 0.01; one-way ANOVA with Tukey’s post-hoc tests; n = 6 (controls), 7 (patients). Scale bar: 50 μm
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structural MRI suggested a close spatial relationship
between this class of WMLs and ePVS at the cortico-
subcortical junction [13], as we have shown here on
post-mortem tissue. This is further evidenced by our
previous histopathological study suggesting that
WMH seen on MRI in the temporal poles of
CADASIL patients are predominantly explained by
ePVS and associated WM degeneration [51].
We confirmed the lack of BBB leakage in “pure”
WMLs in a mouse model of CADASIL, which allowed
us to look at an earlier stage of the disease than is pos-
sible with human post-mortem tissue, such that all
Fig. 4 No blood brain barrier (BBB) leakage in the white matter of CADASIL mice. a-c Immunofluorescent images showing fibrinogen (green) and
capillaries (glut-1; white) in the anterior corpus callosum (CC) of Col4a1+/G498V (a), TgNotch3WT (b), and TgNotch3R169C (c) mice. Fibrinogen staining
is quantified in both the anterior and posterior CC (d). e-g Fluorescent images showing injected cadaverine (red) and capillaries (glut-1; white) in
the anterior CC of Col4a1+/G498V (e), TgNotch3WT (f), and TgNotch3R169C (g) mice. Cadaverine leakage is quantified in both the anterior and posterior CC
(h). Mean ± SEM; ****: p < 0.0001; two-way ANOVA with Tukey’s post-hoc tests; n for each group shown on graphs. Scale bar: 25 μm
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WMLs are “pure” without ePVS or lacunes. While BBB
defects have previously been suggested in this model,
this was only examined in the cortex and only by study-
ing endogenous blood-borne proteins [21]. While the
examination of endogenous proteins is a more
biologically relevant assay of BBB leakage, using this
method alone is not always reliable as these proteins
may have entered the parenchyma by other routes. It is
for this reason that, in this study, we examined both en-
dogenous blood-borne proteins and multiple different
Fig. 5 Normal pericyte coverage and number in the white matter of CADASIL mice. Immunofluorescent images showing capillaries (glut-1; green) and pericytes
(a-b: aminopeptidase-N; c-d: PDGFR-β; red) in the anterior corpus callosum (CC) of TgNotch3WT (a, c) and TgNotch3R169C (b, d) mice. Quantification of pericyte
coverage (e: aminopeptidase-N; g: PDGFR-β) and pericyte number (f: aminopeptidase-N; h: PDGFR-β) shows no difference in the anterior or posterior CC. Mean±
SEM; two-way ANOVA with Tukey’s post-hoc tests; n=8. Scale bar: 25μm
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exogenous injected tracers. Examination of the cortex
is less relevant to the mechanisms of WMLs. More-
over, quantification of a diffuse fluorescent staining in
the cortex of aged animals also introduces the possi-
bility of unreliable measurements due to the presence
of lipofuscin. Lipofuscin appears as autofluorescent
granules around the nuclei of neurons where lyso-
somes accumulate with age, and can be difficult to
distinguish from real fluorescent staining due to its
broad fluorescence emission spectrum [30]. Assuming
that increased fluorescent staining for blood-borne
proteins observed in this previous study [21] was real,
this could be caused by differences in the environ-
ments in which the animals are housed. It has been
shown that differences in gut microbiota can alter the
permeability of the BBB [39]. This, however, does not
detract from the fact that the mice in our colony did
not display any signs of BBB leakage in the WM but
still developed severe WMLs, suggesting that BBB
leakage cannot be the primary cause of these lesions.
We have used a range of techniques to show that there
is no generalised BBB leakage in CADASIL WM, how-
ever our study does have some limitations. One of these
is the variability of immunohistochemical staining tech-
niques between different runs, especially when quantify-
ing a diffuse signal. We minimised this variability by
immunostaining all human samples from a cohort in a
single batch, and analysing each cohort separately. This
batch to batch variability, along with the different brain
bank origins and different imaging platforms used to ac-
commodate larger slides, explains the difference in
values of fibrinogen integrated density between the first
and second human cohorts. Another limitation of our
study is that the techniques used, notably the tracer ex-
periments in the mouse, primarily probed the integrity
of TJs of the BBB, and did not fully exclude the possibil-
ity of a BBB leakage through the transcellular pathway of
increased vesicular transport in endothelial cells. This
possibility can only be fully excluded by analysis of elec-
tron micrographs following injection of biotin or horse
radish peroxidase to mark vesicles. However, pericyte
loss causes both a loss of TJs and an increase in vesicular
transport [2, 12], thus we would expect to see extravasa-
tion of tracers were the hypothesis posited in the intro-
duction correct. Furthermore, endogenous fibrinogen
has been shown to cross the BBB by the transcellular
pathway as well as across TJs [33].
Distinguishing these different types of WMLs is im-
portant, as we show here that ePVS WMLs and WMLs
around lacunes display BBB leakage, while “pure” WMLs
do not, indicating that new avenues need to be explored
to understand the mechanisms behind this type of le-
sion. One possibility is reduced oxygen delivery to these
regions, leading to the death of oligodendrocytes which
are especially sensitive to hypoxia [15]. The reduced ca-
pillary density which we see in these lesions supports the
notion of reduced blood supply causing WMLs, however
it is equally likely that this reduced capillary density may
be a consequence of the reduced metabolic demands in
a demyelinated lesion. Reduced oxygen supply to these
regions could also be due to the impaired cerebrovascu-
lar reactivity which has been reported in the WM of
CADASIL patients [3, 40]. This impaired cerebrovascu-
lar reactivity could also lead to a failure of adequate
drainage of interstitial fluid from the WM along cerebral
arteries, causing a build-up of substances toxic to cells
of the WM [49]. Another possibility is that these lesions
are caused by aberrant signalling from the vasculature to
oligodendroglia, or a lack of trophic support for myelin.
Studies in models of sporadic SVD have shown that sig-
nalling from dysfunctional endothelial cells can cause
WM vulnerability [41]. Recently, it has been shown that
pericytes secrete factors which provide trophic support
to neurons, and these factors may also play a similar role
for myelin [34]. In CADASIL mice, it has been shown
that vitronectin accumulation around blood vessels plays
an important role in the development of WMLs [5], and
it may be that this and other factors signal to oligoden-
drocytes and alter the stability of myelin.
Conclusions
Here, we have demonstrated that BBB leakage is not a
consistent feature of WMLs in CADASIL, and is only
present where there are lacunes or ePVS. Thus, it is un-
likely to be the primary mechanism of pure WM damage
in this disease. These findings may also have implica-
tions for sporadic SVD and other dementias in which
WMLs are present [23].
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